UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
SCHEDULE 14C INFORMATION
 
Information Statement Pursuant to Section 14(c)
of the Securities Exchange Act of 1934
 
 
Filed by the Registrant  
Filed by a Party other than the Registrant  
 
Check the appropriate box:
 
  Preliminary Information Statement
  Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2))
  Definitive Information Statement
 
 
 Cellular Biomedicine Group, Inc.
(Name of Registrant as Specified In Its Charter)
 
Payment of Filing Fee (Check the appropriate box):
 
  No fee required
 
  Fee computed on table below per Exchange Act Rules 14c-5(g)(1) and 0-11.
 
(1)  Title of each class of securities to which transaction applies:
(2)  Aggregate number of securities to which transaction applies:
(3)  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4)  Proposed maximum aggregate value of transaction:
(5)  Total fee paid:
 
  Fee paid previously with preliminary materials.
 
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
 
(1)  Amount Previously Paid:
(2)  Form, Schedule or Registration Statement No.: 
(3)  Filing Party: 
(4)  Date Filed:
 

 
 
 
 
 
 
 
CELLULAR BIOMEDICINE GROUP, INC.
CONTROL ID:
 
REQUEST ID:
 
 
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
for the Annual Meeting of Stockholders to be Held on June 26, 2020.
 
 
TIME:
9:00 AM Eastern Standard Time
 
LOCATION:
Aloft Long Island City – Manhattan View
27-45 Jackson Avenue, Long Island City, New York 11101
 
 
 
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS
 
PHONE:
Call toll free
1-866-752-8683
FAX:
Send this card to
202-521-3464
INTERNET: 
https://www.iproxydirect.com/CBMG 
and follow the on-screen instructions.
EMAIL:
proxy@iproxydirect.com
Include your Control ID in your email.
 
This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/CBMG
 
If you want to receive an e-mail or paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To facilitate timely delivery please make the request, as instructed above, before June  15, 2020.
 
You may enter your voting instructions at https://www.iproxydirect.com/CBMG until 11:59 pm eastern time June 25, 2020.
 
 
The purposes of this meeting are as follows: 
 
 
 
(1)  Elect three (3) “Class II” directors, each of whom will be elected for a three-year term, or until the election and qualification of their successors;
(2)  Ratify the appointment of BDO China Shu Lun Pan Certified Public Accountants LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
(3)  Conduct a non-binding advisory vote to approve the compensation of our named executive officers; 
(4)  Conduct a non-binding advisory vote recommending the frequency of future advisory votes on the compensation of our named executive officers; and
(5)  Transact any other business properly brought before the Annual Meeting or any adjournments thereof.

 
Pursuant to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual Meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.
 
The Board of Directors has fixed the close of business on April 27, 2020 as the record date for the determination of stockholders entitled to receive notice of the Annual Meeting and to vote the shares of our common stock, par value $.001 per share, they held on that date at the meeting or any postponement or adjournment of the meeting.
 
The Board of Directors recommends that you vote “FOR” each of the nominees on Proposal Number 1, “FOR” on Proposals Number 2 and 3, and “THREE YEARS” on Proposal Number 4.
  
Please note - This is not a Proxy Card - you cannot vote by returning this card
 
 
 
 
 
 
 
 
 
 
Cellular Biomedicine Group, Inc.
SHAREHOLDER SERVICES
500 Perimeter Park Drive Suite D
Morrisville NC 27560
 
 
 
 
 
TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IMPORTANT SHAREHOLDER INFORMATION
 
YOUR VOTE IS IMPORTANT